Documenti di Didattica
Documenti di Professioni
Documenti di Cultura
ABSTRACTS
653
657
Synthesis of C$5ymmetric
Inhibitors of the HIV-l Protease, with
N,N-Substituted Ethylenediamide and Ethylenediamine Linkers.
J. P. Mazalcyrat*, I. Rage, J. savrda, M. Mouna and M. Wakselman. CNRSCERCOA, 2, rue Hem Dunant, F-94320 Thiais, France.
R. Boulay and Y. L&&e. Rhdne-PoulencRarer, 13, quai Jules Guesde. F94403 Vitty-sur-Seine. France.
C2-symmetric compounds [Z-Val-Phe-N(R)CH2-12
(I: X= CO; R= H,
CH3) and [Z-V&Phe(PCH2N)-N(R)CH2-12
(I: X= CH2; R= H, CH3;
CH2-COOH;
CH2-CH2-OH)
have been synthesized.
They are
moderately active inhibitors of the HIV-l protease.
Ca2+-ATPase
INHIBITORY
ACTIVITY
OF A LOCKED
ANALOGUE
OF THAPSIGARGIN
Annette Andersen, Marek Treiman, Claus Cornet&, Peter Moldt, Jens-Christian J. Paulsen,
Carl Erik Olsen and S. Bmgger Christensen * . * PharmaBiotec, Department of Medicinal
Chemistry, Royal Danish School of Pharmacy, Universitetsparken
2,
DK-2100 Copenhagen, Denmark.
preparation of a non-ionic desoxy-analogue
of thapsigarin locked as a furane is described. The
analogue possesses a Ca2+-ATPase inhibitory
potency similar to that to that of thapsigargin.
The
661
667
PeterJ.Sharmtt*,JulieL.~GrahamG.A.Inglis,MichaelG.Lester,
Paaayiotis A. Roqiou aad Nigcl S. Watsoa.
Glaxo GroupResemh Ltd.,Greenm. Middlesex, LIB6OHE. UK.
Monwyclicanalo~ofthesqualestatinsbase4lona1,3dioxawringwcre
preparedandevaluatsd6wtheirebilitytoinhibit~~ir,wbo.
The
compouad 16a possehag a 4,6dime&ylockaoy~l
grmp at C4 aad a
mboxam&atC2showedpotcatinhibitcsyacti&y(lCso11aM).
5-HTq RECEPTOR
ANTAGONISTS:
OXAZOLO,
P.A.Wyman
DERIVATIVES
derivatives
The oxazino[3,2-alindole
(4) has a
pIC50 of 10.6 in the guinea-pig isolated distal colon model of the receptor.
I
645
PERHYDROTHIOPYRANOPYRROLES
DERIVATIVES:
A NOVEL SERIES OF POTENT AND SELECTIVE
NONPEPTIDE NKl SUBSTANCE P ANTAGONISTS.
D . Achard, A . Truchon and J -F . Peyronel* Rhbne-Poulenc Rorer Central Research, Medicmal Chemrsfry
Department, Centre de Recherches de Vitty-A~ortville,
B.P. 14, 94403 VITRY sur SEINE Cedex FRANCE.
The synthesis of RP 73467, a reprwntative of
4,4diphenyI ~ydrothiopyrano[2,3c]pyrroles
l-oxides,
a new series of potent and selective nonpeptide NK 1
substance P antagonists, IS described.
669
RP 73467
I
EMD 61756
AS A FAVOURABLE REPRESENTATIVE OF
STRUCTURALLY NOVEL ARYLACETAMIDO-TYPE
K OPIATE
RECEPTOR AGONISTS
Ft. Goltschlich, K. A. Ackemxann, A. Bad&,
G. D. BartcszykW, H. E. Greinefl
* Medicinal Chemistry Department, # Biological Research Department
E. Merck, D-64271 Darmstadt, Federal Republic of Germany
611
-I
646
A series of (i)-AJ76 and (+)4BiZ32 anaiogswith theC-5 metboxy group modified was synthesized and biologically
evaiuated. Compounds with a tridate or nitrile group were found to he behavioral stimulants with high metabolic
stability. The triflate analogs also displayed a 14 fold preference for the D3 receptor site in vitro.
Pymzolofl $-a]pyridlncts
as !iHT&ntagonkts
and Pyrazolo[1+b]pyridazines
1994,4,695
X:
CH N
Y:
NH
R: H
CH,
H,CO
A series of aza-combratastatin
R = H, (cH~)&H, ( n = 0 - 5 1
f (CH~)~CO~~
= (CH&@i20H
d~nstit&
Tmatment of a Aryan
model PYML-6 with mouse liver extract resulted in the hy~iysis
of the carbamoyl group of the axial side &ii to give an inactive product deamido-PYh=fL.-k
demonsting the~-~~~i~i~
moiety tube an ~zyrne-~~~nt
switch of activity.
647
of
Me0
PYML-6 R..CONH, H
deamido-PY~-6
R = CO2H
ACTIVITY OF
ENEDIYNE CHEMOTYPES
and Nada Zein; Bristol-Myers Squibb Pharmaceutical Research Institute, 5 Research Parkway,
Connecticut
Wallingford,
A series of electronically and sterically altered enediyne cores, based on esperamicin were prepared and
evaluated as antitumor agentsin both in vitro and in viva models.
SH
+ CBZ-NH&
CONH 1-B
Br
715
IN 46285
CONH I-Bu
CBZNHJLS
d
m 8 steps and
0
ti
HO
OF
D B Judd*, K S Cardwell, T A Pan&d, T.I. Jack, M Pass, T. Hubbard, A.W. Dean, AU Butt,
J E Hobson, N M. Heron, S P. Watson, G.S Curie, D tiddlemiss,
D.G Allen, N.M Aston,
J M S Paton, G M Drew, A Hilditch, D Gsllacher, M K Elayliss, and M C Donnelly
648
SYNTHESIS OF B-NOR+AZA&x-ANDROSTANE
COMPOUND AS Sa-REDUCTASE INHIBITOR
Koki Ishibashi, Hitoshi Kurata, Koichi Kojima. and Hiroyoshi Horikosh?
1994,4,729
Ph
N4Ph
B-Nor4aza-Sa-andmstane
Ll@
N
H
1
S-S
OF CYCLOHEXYL
RESTRICTWIN
ANALOGS OF
Rd)9-2056:
x=N
ROW-2127:
x=CH
potfzntialmekxl(MLP)inordertoquatWythe
chruneleon? behavior(hydrophilicin water,
lipophilicin lipidicmedia)ofthex compounds.
c+,
649
BioMed.
cxN
NS".P,
N
x
SYNTHEXS OF
ti
II: R = CC& 0
III: R = CN.+H
I Btoh4ed
. .Chern.Lea
ARTEMISININ DERIVATIVE.
x994,4,
751
Y.Ogawa,Y.Yamazaki,*
and H. Okuno
NationalInstituteofBioscience and Human Technology,AIST, Tsukuba,ibaraki 305, Japan
The stereoseie~tivi~
ofcancercefls
forester
hydrolysis
isdifferent
fromthatofn~alcelIs
ofrat.
rat normal pancreas
*
34.1 %e.e.
(S) - 5
83.9%e.e.
650
761
A.D. Shutalev. I.E. Mikerin,B M Arshava. A.A. Nikilenko. Y.E. Raifeld.G.Y. VidZ, V.J. Lee* , GV Gunkaya. L.S. Viktomva~
M.V. Jasko, D.G. Semizar&. V.E Zavodnik
Laboratoryof Carbohydralesand Nucleoside Synlhesis Moscow Insr~tuteof Pine Chemical Technology and JVAngarex
Moscow 117571, Russia
Medical Research Division, American Cyanamid Company. Pearl River. New York IO965
Instituteof Molecular Biology RAS and lnstiluteof Physical Chemistry.Moscow, I 17915. Russia
651